<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Amyloid-β (Aβ), a natural product of cell metabolism, plays a key role in the pathogenesis of <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e> (AD) </plain></SENT>
<SENT sid="1" pm="."><plain>Epidemiological studies indicate patients with AD have an increased risk of developing type 2 <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo> (T2DM) </plain></SENT>
<SENT sid="2" pm="."><plain>Aβ can induce <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> in cultured hepatocytes by activating the JAK2/STAT3/SOCS-1 signaling pathway </plain></SENT>
<SENT sid="3" pm="."><plain>Amyloid precursor protein and presenilin 1 double-transgenic AD mouse models with increased circulating Aβ level show impaired <z:chebi fb="105" ids="17234">glucose</z:chebi>/insulin tolerance and hepatic <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>However, whether Aβ induces hepatic <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> in vivo is still unclear </plain></SENT>
<SENT sid="5" pm="."><plain>Here we show C57BL/6J mice intraperitoneally injected with Aβ42 exhibit increased fasting blood <z:chebi fb="105" ids="17234">glucose</z:chebi> level, impaired insulin tolerance, and hepatic insulin signaling </plain></SENT>
<SENT sid="6" pm="."><plain>Moreover, the APPswe/PSEN1dE9 AD model mice intraperitoneally injected with anti-Aβ neutralizing antibodies show decreased fasting blood <z:chebi fb="105" ids="17234">glucose</z:chebi> level and improved insulin sensitivity </plain></SENT>
<SENT sid="7" pm="."><plain>Injection of Aβ42 activates hepatic JAK2/STAT3/SOCS-1 signaling, and neutralization of Aβ in APPswe/PSEN1dE9 mice inhibits liver JAK2/STAT3/SOCS-1 signaling </plain></SENT>
<SENT sid="8" pm="."><plain>Furthermore, knockdown of hepatic JAK2 by tail vein injection of adenovirus inhibits JAK2/STAT3/SOCS-1 signaling and improves <z:chebi fb="105" ids="17234">glucose</z:chebi>/insulin tolerance and hepatic insulin sensitivity in APPswe/PSEN1dE9 mice </plain></SENT>
<SENT sid="9" pm="."><plain>Our results demonstrate that Aβ induces hepatic <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> in vivo via JAK2, suggesting that inhibition of Aβ signaling is a new strategy toward resolving <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> and T2DM </plain></SENT>
</text></document>